Investing News

With some of the most recognizable and successful brands including Crest, Gillette, Pampers, Dawn, and Charmin in its vast portfolio, Procter & Gamble (PG) serves nearly five billion people around the world. Based in Cincinnati, Ohio, with operations in 180 countries, P&G is also the world’s largest advertiser.

The largest owners of P&G stock are institutional investors, like BlackRock and Vanguard, both of which hold large stakes on behalf of their clients. But among individual shareholders, the list of top P&G shareholders includes many of the executives and board members who have helped build the company in recent years. The facts and figures listed are current as of the most recent proxy statement filed by the company with the Securities and Exchange Commission (SEC) on Aug. 28, 2020.

Key Takeaways

  • Procter & Gamble (PG) is a multinational consumer goods corporation with operations in 180 countries.
  • The largest shares of PG stock are held by institutional investors and fund managers.
  • Among individuals, the largest shareholders are company executives and board members, who receive the stock in compensation.
  • David Taylor is the largest shareholder of PG stock, with over 12 million common shares.
  • On November 1, 2021, Jon Moeller will succeed David Taylor to become President and CEO of Procter & Gamble.

David S. Taylor

David Taylor is the largest individual shareholder of Procter & Gamble, with more than 12 million common stock. He became the third chief executive officer (CEO) of P&G in three years on Nov. 1, 2015, and was named chair of the board on July 1, 2016. Widely considered a dark horse to take over the company’s leadership after A.G. Lafley’s departure, Taylor became the clear front-runner after being handed the reins of the global beauty division earlier in the year. Taylor’s unique career path to CEO began in 1980 after receiving a degree from Duke University in electrical engineering. He began as a plant manager and moved his way up, holding many senior executive positions within the company.

In 2021, it was announced that Taylor would step down as president and CEO to become Executive Chairman, effective November 1, 2021.

Jon R. Moeller

Jon R. Moeller is Procter & Gamble’s newest President and Chief Executive Officer, effective November 1, 2021. He joined P&G in 1988 as a cost analyst, and became the company’s chief financial officer (CFO) in 2009. He also served as chief operating officer (COO) and the company’s vice chair, before succeeding David Taylor as President and CEO.

Moeller worked in almost every aspect of P&G, with extensive experience in the China market and its global beauty care division. He has overseen the divestitures of Folgers, the company’s pharmaceutical operation, and the $12.5 billion merger of Coty (COTY). To date, he owns 748,113 common shares of PG stock, as well as 62,162 restricted shares.

Steven Bishop

Steven Bishop heads up P&G’s Health Care business, which has a billion-dollar portfolio of products under famous brands such as Crest, Vicks, and Oral-B. Prior to his appointment in 2019, he served as Group President for P&G’s departments in Global Oral Care and Global Feminine and Family Care. He intends to retire in 2022. As CEO-Health Care, Bishop owns 599,891 units of P&G common stock, as well as 41,807 units of restricted stock.

David Taylor became P&G’s third CEO in three years in November 2015.

Mary Lynn Ferguson-McHugh

After graduating from Wharton’s MBA program in 1986, Ferguson-McHugh joined P&G and was appointed CEO of Family Care and P&G Ventures. Between personal and family holdings, she owns 403,103 common shares of the company as well as 64,630 restricted shares.

Carolyn Tastad

Carolyn Tastad has been listed on Fortune’s most powerful women list for four years in a row, from 2015 to 2018. After heading up P&G’s North American business operations, she was appointed to the role of CEO-Health Care in 2021. Tastad owns 241,021 shares of PG common stock, as well as 51,007 restricted shares.

Articles You May Like

Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Greenlight’s David Einhorn says the markets are broken and getting worse
Hedge funds performed better under Democratic presidents than Republican ones, history shows
Gary Gensler reviews his accomplishments, says he was ‘proud to serve’ as SEC chair
AI’s Dark Horse Could Become Its Crown Jewel Under Trump